Valproic acid

CAS No. 99-66-1

Valproic acid ( VPA;2-Propylpentanoic Acid )

Catalog No. M16914 CAS No. 99-66-1

A HDAC inhibitor that selectively inhibits the catalytic activity of class I HDACs, and induces proteasomal degradation of HDAC2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 45 In Stock

Biological Information

  • Product Name
    Valproic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    A HDAC inhibitor that selectively inhibits the catalytic activity of class I HDACs, and induces proteasomal degradation of HDAC2.
  • Description
    A HDAC inhibitor that selectively inhibits the catalytic activity of class I HDACs, and induces proteasomal degradation of HDAC2; induces differentiation of carcinoma cells, transformed hematopoietic progenitor cells and leukemic blasts from AML patients; reduces tumor growth and metastasis formation in animal model.Migraine Approved
  • Synonyms
    VPA;2-Propylpentanoic Acid
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    GABA; Sodium Channel; HDACs
  • Research Area
    Neurological Disease
  • Indication
    Migraine

Chemical Information

  • CAS Number
    99-66-1
  • Formula Weight
    144.21
  • Molecular Formula
    C8H16O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in H2O
  • SMILES
    CCCC(CCC)C(O)=O
  • Chemical Name
    Pentanoic acid, 2-propyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Krmer OH, et al. EMBO J. 2003 Jul 1;22(13):3411-20.
2. Gttlicher M, et al. EMBO J. 2001 Dec 17;20(24):6969-78.
3. Phiel CJ, et al. J Biol Chem. 2001 Sep 28;276(39):36734-41.
molnova catalog
related products
  • T326

    A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM.

  • CHDI-390576

    CHDI-390576 (CHDI390576) is a potent, cell permeable and CNS penetrant class IIa HDAC inhibitor.

  • Crebinostat

    Crebinostat is a novel cognitive enhancer that inhibits class I HDAC/1/2/3.